Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal Cancer

Clinical trial NCT00407563 · COMPLETED

Trial details

NCT number: NCT00407563
Sponsor: Accelerated Community Oncology Research Network
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Epithelial Ovarian Cancer Primary Peritoneal Carcinoma

Start date: 2007-01-01
Primary completion: 2011-02-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.